Related Experiment Video
Updated: Feb 26, 2026

The Mesenteric Lymph Duct Cannulated Rat Model: Application to the Assessment of Intestinal Lymphatic Drug Transport
Published on: March 6, 2015
Is there an association between mesenteric panniculitis and lymphoma? A case control analysis
V Khasminsky1, E Ram2, E Atar1
1Department of Diagnostic Imaging, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mesenteric panniculitis (MP) affects 1.8% of non-Hodgkin
Area of Science:
- Radiology
- Oncology
- Gastroenterology
Background:
- Mesenteric panniculitis (MP) is a rare condition affecting the mesentery.
- Its association with non-Hodgkin's lymphoma (NHL) is debated.
- Radiological imaging plays a key role in diagnosis.
Purpose of the Study:
- To investigate the prevalence of MP in patients with NHL.
- To compare MP prevalence in NHL patients versus a control group.
- To determine if MP is associated with NHL.
Main Methods:
- Retrospective analysis of CT and PET-CT scans from 166 NHL patients and 332 controls.
- Diagnosis of MP based on radiological signs and absence of FDG-uptake.
- Exclusion of mesenteric involvement by lymphoma.
Main Results:
- MP prevalence was 1.8% in NHL patients and 2.1% in controls (p=0.556).
- No significant difference in MP prevalence between the groups.
- Mesenteric changes attributed to lymphoma occurred in 16.2% of NHL patients.
Conclusions:
- The prevalence of MP in NHL patients is similar to the general population.
- This study does not support an association between MP and NHL.
- MP diagnosis requires careful differentiation from lymphoma involvement of the mesentery.
More Related Videos
05:43The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
Published on: August 1, 2025
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024